Raymond James & Associates’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-48,254
| Closed | -$394K | – | 3728 |
|
|
2020
Q3 | $394K | Buy |
48,254
+34,203
| +243% | +$279K | ﹤0.01% | 2776 |
|
|
2020
Q2 | $97K | Buy |
14,051
+1,119
| +9% | +$7.73K | ﹤0.01% | 3255 |
|
|
2020
Q1 | $61K | Buy |
+12,932
| New | +$61K | ﹤0.01% | 3263 |
|
|
2019
Q1 | – | Sell |
-20,961
| Closed | -$71K | – | 3580 |
|
|
2018
Q4 | $71K | Buy |
+20,961
| New | +$71K | ﹤0.01% | 3325 |
|